ahlam1399
09-16-2016, 04:50 PM
**vo **rdisk?s diabetes drug semaglutide cuts heart risk by 26 percent
COPENHAGEN (Reuters) - **vo **rdisk's experimental injectable diabetes drug semaglutide reduced cardiovascular risk by 26 percent according to the keenly awaited results of a clinical trial released on Friday.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=eOkBV4z1LWw:20jGI6p7r-c:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=eOkBV4z1LWw:20jGI6p7r-c:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=eOkBV4z1LWw:20jGI6p7r-c:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=eOkBV4z1LWw:20jGI6p7r-c:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=eOkBV4z1LWw:20jGI6p7r-c:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/eOkBV4z1LWw
COPENHAGEN (Reuters) - **vo **rdisk's experimental injectable diabetes drug semaglutide reduced cardiovascular risk by 26 percent according to the keenly awaited results of a clinical trial released on Friday.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=eOkBV4z1LWw:20jGI6p7r-c:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=eOkBV4z1LWw:20jGI6p7r-c:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=eOkBV4z1LWw:20jGI6p7r-c:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=eOkBV4z1LWw:20jGI6p7r-c:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=eOkBV4z1LWw:20jGI6p7r-c:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/eOkBV4z1LWw